Lupin shares rise most on BSE 
The stock of pharmaceutical major Lupin on Monday rose the most on BSE after a notification that the inspection carried out by the US FDA at its Goa facility is now closed. The stock was trading 7.33% higher. "We are grateful for the US FDA's confidence in our corrective action plan and in our team," the company said.